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Abstract
Concerning allergic diseases, the incidence of allergic symptoms, as well as their severity, seems to
decrease with age. The decline of onset of allergic symptoms observed in ageing might result from
a decrease of serum total and specific IgE. Atopic disorders are complex diseases that involve
interactions among several physiological systems, e.g. skin, lung, mucosae, and the immune system.
It was the aim of this study to compare the effects of age on total and specific IgE in patients with
atopic dermatitis (AD), allergic rhinitis or asthma, and insect allergy, respectively.
The study population consisted of 559 individuals (male: 229 and female: 330). Total and allergen
specific IgE was measured in every individual. From the whole study population, 113 patients
suffered from atopic dermatitis (AD), 132 had allergic rhinitis or asthma, and 314 were tested
because of insect allergy. Total and specific serum IgE was significantly decreased as a function of
age in patients with allergic rhinitis and asthma and with insect allergy. In contrast, no significant
decrease of total and specific serum IgE in old individuals with AD was observed. Additionally, in
the group of patients with a total IgE < 300 kU/l a reduction of total serum IgE was significantly
correlated with age. In contrast, patients with IgE levels > 300 kU/l showed no correlation with age.
Immunosenescence does not affect increased IgE levels in atopic patients with AD and/or high
serum IgE levels indicating that in these subgroups of patients the atopic propensity remains into
advanced age. One may hypothesize that either onset of allergic sensitization during life or the kind
of atopic disease influences the correlation between age and IgE synthesis.
Introduction
Concerning allergic diseases, the incidence of onset of
allergic symptoms, as well as their severity seems to
decrease with age [1]. Atopy is a relatively common,
adverse humoral immune system response to common
environmental agents (allergens) involving the produc-
tion of allergen-specific IgE. Epidemiological investiga-
tions of allergen sensitivity in a community-based
population [2-5] and an industrial setting [6,7] show that
the propensity for and the relative incidence of atopic dis-
orders tend to change with age. Serum total IgE values
decline with age in the general population, and there are
significantly fewer cases of atopy among elderly subjects
(60 years and older) compared with younger subjects.
However, atopic disorders are complex diseases that
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involve interactions among several physiological systems,
e.g. skin, lung, mucosae, and the immune system.
The immune system undergoes characteristic changes
with ageing. Most tests of T cell function are depressed in
elderly individuals and the deterioration of the immune
systems is believed to contribute to morbidity and mortal-
ity in man [8].
Age-associated alterations in the proportions of T cell sub-
sets have been well documented in humans. There are
clearly more CD4+ CD45RO+ "memory-phenotype" cells
and less CD45RA+ "naïve-phenotype" cells in peripheral
blood mononuclear cells (PBMC) from elderly individu-
als. The accumulation of CD45RO+ memory cells results
in a reduced ability to respond to new antigens, and a
retained ability to respond to recall antigens, as long as
the memory cells remained present and functional [9-11].
Data on age-associated alterations in cytokine secretion in
human are inconsistent. Th1 cells are characterised by
their ability to secrete IFNγ , IL-2, TNF-α , IL-12 and IL-15,
whereas Th2 cells are characterised by IL-4, IL-5, IL-6, IL-
10 and IL-13 secretion. Infant humans exhibit impaired
cellular but strong humoral immunity, and are in a type 2-
dominant state. Soon thereafter, a type 1-state becomes
dominant and persists in healthy humans until mid-to-
later life, at which time a dominant type 2 cytokine profile
may again emerge [12]. Paradoxically, despite declining T
cell function, ageing does nor appear always to be associ-
ated with decreased immune reaction. For instance, there
are increased levels of autoantibodies in the aged [13],
resulting in autoimmune diseases (e.g. bullous
pemphigoid).
Current thought posits that age-associated changes in B-
cell function are primarily due to changes in the T-cell
compartment and a resultant dysregulation on B-cell
function [14]. Altered function is primarily associated
with exposure to "new" antigenic challenges, as for exam-
ple the less efficient therapeutic value of inoculation
regimes among the elderly population. Although both T
cells and B cells are involved with the onset of atopy, the
effector mechanisms are principally humorally driven and
focused on the production and regulation of IgE. To what
extent this regulation is T cell dependent or T cell inde-
pendent is not well stablished. Recently, it has been dem-
onstrated that in healthy non-atopic individuals no
differences in either serum total IgE and soluble CD23 or
Th2 related cytokines (IL-4, IL-10 and IL-13) between
young and old subjects were observed [15].
However, there are not many studies investigating the
relationship between age and IgE in different atopic dis-
eases. In this study, we evaluated the effects of age on total
and specific IgE in patients with atopic dermatitis (AD),
allergic rhinitis or asthma, and insect allergy.
Methods
Study population
The population of this retrospective study consisted of
559 individuals (male: 229 and female: 330) randomly
selected from a data bank of patients diagnosed for one of
the relevant diseases. The diagnoses were made on the
basis of the case history and the clinical examination.
Total and/or allergen specific IgE was measured in every
individual. From the whole study population, 113
patients suffered from AD, 132 had allergic rhinitis or
asthma, and 314 were tested because of insect allergy.
Determination of serum IgE
Total and allergen specific serum IgE was measured by
using the UniCAP System (Pharmacia, Freiburg, Ger-
many) according to the instructions of the manufacturer.
Directly after collection of venous blood, the blood was
centrifuged and serum was stored at -20°C until testing.
Total serum IgE levels < 300 kU/l are in the normal or bor-
derline range, amounts ≥  300 kU/l were classified as path-
ological [17]. Serum IgE specific was determined at least
for one of the following antigens: Dermatophagoides
pteronyssinus and farinae (Der p 1 and Der f 1), Betula
verrucosa (Bet v 1), Phleum pratense (Phl p 1), Felis
domesticus (Fel d 1), and hymenoptera venoms. In
patients with allergic asthma or rhinitis and in patients
with AD Der p 1 and Der f 1, Bet v 1, Phl p 1, and Fel d 1
were measured. In patients with insect allergy specific IgE
to hymenoptera venoms was tested. For patients polysen-
sitized against several allergens, the highest value of spe-
cific IgE was selected and only this value was used for
statistical analysis.
Statistical analysis
Statistical analysis for paired comparisons of total and
specific IgE between different patient groups was con-
ducted by Student's t test. In order to assess the relation-
ship between IgE and age, we calculated Kendall's tau-b
and the corresponding p-values to test the hypothesis that
both variables are not associated [18]. Additionally, we
used simple linear regression to evaluate age-associated
changes in serum IgE. Statistical analysis was performed
by using the software program SPSS 9.0.
Results
Patients characteristics
The study population consisted of 559 patients suffering
from either AD (n = 113), allergic asthma or rhinitis (n =
132) or insect allergy (n = 314) tested for total and specific
serum IgE (Table 1). Mean age of patients with AD was
23.5 years, whereas mean age of the patients with allergic
rhinitis, asthma or insect allergy was 36.7 years and 44.2Immunity & Ageing 2005, 2:9 http://www.immunityageing.com/content/2/1/9
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years, respectively (Table 1). In the group of patients > 65
year old 6 (5.3%) had AD, 24 (18.2%) sufferd from rhin-
itis or asthma, and 105 (33.4%) from insect allergy. Twen-
tytwo patients with insect allergy were younger than 10
years. In the group of patients with insect allergy older
than 65 years the onset of symptoms was always over 60
years but not in the group of patients with AD and allergic
rhinitis or asthma where symptoms onset always started
earlier. Independent of age, the highest amounts of total
and specific IgE (Figure 1) were found in patients with AD
compared with the other patient groups (p < 0.01; p <
0.02).
Ageing and total serum IgE
The total IgE had a negative correlation (p < 0.0001) with
age in all patients as well as in the subgroups of patients
with allergic rhinitis and asthma, and insect allergy. In
contrast, no significant decrease of total serum IgE as a
function of age was observed in patients with AD (Table
1).
Figure 2 shows the values of total serum IgE (kU/l) against
donors age for patients with AD, allergic asthma or rhini-
tis, and for insect allergy. For patients with allergic asthma
and rhinitis (F(1,130) = 10.850, p = 0.001) as well as for
patients with insect allergy (F(1,307) = 16.236, p <0.0001),
the slopes of the lines derived from simple linear regres-
sion do vary significantly from zero, but do not for
patients with AD (F(1,110) = 1,734, p = 0.191).
Additionally, in the group of patients with a total IgE <
300 kU/l a reduction of total serum IgE was significantly
correlated with age (p <0.0001). In contrast, patients with
IgE levels > 300 kU/l showed no correlation with age
(Table 2). From the patients with IgE levels > 300 kU/l, 16
(11.9%) were over 65 years old. Linear regression analysis
revealed F(1,400) = 20.955 (p <0.0001) for total IgE levels <
300 kU/l but were not significant for IgE levels > 300 kU/
l (F(1,149) = 1,138, p = 0.288)
Ageing and allergen specific IgE
Figure 1 shows specific IgE values for each tested allergen
in the different disease groups. No significant differences
of mean IgE values between the different allergens could
be detected except in patients with insect allergy. In
patients with insect allergy only wasp and bee allergen
were tested and the mean specific IgE for bee was signifi-
cantly (p = 0.02) lower compared with wasp specific IgE.
The majority of these patients (91.7%) had immuno-
therapy because of wasp allergy, whereas 8.3% had immu-
notherapy because of clinical relevant sensitization (Table
3). In patients with atopic dermatitis or with rhinitis/aller-
gic asthma relevant sensitization (0.35 kU/l) against the
different allergens was distributed homogenously. Only
sensitization to Fel d 1 was less frequent in patients with
allergic rhinitis or asthma (Table 3).
Allergen specific IgE was significantly decreased in the eld-
erly suffering from allergic rhinitis, allergic asthma (p <
0.0001) and insect allergy (p = 0.029), respectively. On
the other hand, no correlation between specific IgE and
age was observed in patients with AD (Table 1).
For patients with allergic asthma and rhinitis (F(1,130) =
26.437, p = 0.0001) the slopes of the lines derived from
simple linear regression do vary significantly from zero
(Figure 2). For patients with insect allergy (F(1,308) = 0.110,
p = 0.740) and for patients with AD (F(1,68) = 0,283, p =
0.596), linear regression did not reveal significant varia-
tion from zero for allergen specific IgE (Figure 2).
Discussion
From a clinical perspective, supported by epidemiological
investigations, there would appear to be a decline with age
in both the incidence and severity of atopic diseases, par-
ticularly among the elderly population who are 60 years
and older [2-7]. Atopic incidence declines, symptoms
severity declines, and there would appear to be a general
humoral alteration of the propensity for atopy reflected by
age-associated declines in serum total IgE values. How-
ever, the results of this study demonstrate that the associ-
ation between age and serum IgE is dependent on the type
of atopic or allergic disease and is also dependent on the
amount of total serum IgE.
The results of our study are supported by data that have
been published recently by Jackola et al. [16]. In patients
with allergic asthma they observed a decline with age in
Table 1: Correlation between age and IgE. Characteristics of patients and Kendall's tau-b for relationship between IgE and age.
Mean Age ± SD (range) Age (yr) Number of patients (%) Total IgE [kU/l] vs Age Specific IgE [kU/l] vs Age
>65 >65 male female τ b (n) p τ b (n) p
All patients 36.9 ± 22.6 (0.5 – 93) 424 135 229 (40.9) 330 (59.0) -0.262 (553) < 0.0001 -0.176 (485) < 0.0001
Atopic dermatitis 23.6 ± 20.1 (0.5 – 93) 107 6 53 (46.9) 60 (53.1) -0.038 (112) = 0.561 0.034 (68) = 0.696
Allergic Rhinitis/Asthma 36.7 ± 19.6 (3.0 – 79) 108 24 50 (37.9) 82 (62.1) -0.219 (132) < -0.0001 -0.320 (107) < 0.0001
Insect Allergy 44.2 ± 21.7 (2.0 – 82) 209 105 126 (40.1) 188 (59.9) -0.259 (309) < 0.0001 -0.084 (310) = 0.029Immunity & Ageing 2005, 2:9 http://www.immunityageing.com/content/2/1/9
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serum total IgE values. Moreover, they showed that
among those asthmatic individuals sensitized to ragweed
antigen, there was no age-associated change in IgE levels
specific to the major ragweed allergen. This robustness of
the underlying atopic mechanism, represented by specific
IgE was also observed in our patients with AD but not in
the patients with allergic asthma or rhinitis and in patients
with insect allergy. Concerning insect allergy, this
difference might be partly explained by the later onset of
sensitization against hymenoptera venoms during life and
thus, other immunological mechanisms regulating the
production of specific IgE in patients with insect allergy,
which has been defined as hypersensitivity allergic nonat-
opic IgE-mediated disease [17]. This assumption is sup-
ported by the fact that in the group of patients with insect
allergy older than 65 years the onset of symptoms was
always over 60 years but not in the group of patients with
AD and allergic rhinitis or asthma.
The differences according age-association of allergen-spe-
cific IgE in patients with asthma between the two studies
might be the consequence of patient's selection. The sub-
group of patients with asthma in our study probably was
more heterogenous compared with the population inves-
tigated by Jackola and co-workers. Moreover, it is not clear
whether asthma patients with additional manifestations
of other atopic diseases (e.g. AD or rhinitis) were excluded
in their study or not.
As expected, the numbers of patients with AD older than
60 years were rather small. However, a higher proportion
of AD patients were over 40 years old indicating that in
this group of adults IgE production is unaffected by age.
The results of our study support the assumption that age-
association of total and specific serum IgE is dependent
on the type of atopic disease the patients are suffering
from and the age at disease onset.
Conclusion
In summary, this study shows that total and allergen spe-
cific IgE production is reduced in the elderly with the
exception of old patients with either high serum IgE or
AD, indicating that atopic mechanisms underlying AD or
other atopic diseases with high serum IgE are particularly
robust, and the atopic propensity among these patients
remains into advanced age. However, further studies are
required to clarify the immunological mechanisms which
are responsible for IgE synthesis during
immunosenscence.
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Total and specific IgE levels Figure 1
Total and specific IgE levels. Means ± SEM of total and 
specific IgE [kU/l] for Der p 1/f 1, Bet v 1, Phl p 1, and Fel d 1 
in patients with (a) AD and with (b) allergic asthma or rhinitis 
as well as for (c) wasp and bee allergen in patients with insect 
allergy are shown. Total and specific IgE is sicnificantly 
increased in patients with AD compared with patients suffer-
ing from allergic asthma or rhinitis and insect allergy.
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Correlation between age and IgE Figure 2
Correlation between age and IgE. Multiple scatter plots of donor age versus total (● ) and specific (❍ ) serum IgE. (a) 
patients with AD, (b) patients with allergic asthma or rhinitis; (c) patients with insect allergy. R1, line for total IgE and R2 for 
specific IgE derived from simple linear regression.
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